Potential role of N-benzylcinnamide in inducing neuronal differentiation from human amniotic fluid mesenchymal stem cells

Wipawan Thangnipon, Nicha Puangmalai, Nirut Suwanna, Rungtip Soi-ampornkul, Ruchee Phonchai, Naiphinich Kotchabhakdi, Sujira Mukda, Tatsanee Phermthai, Suphakde Julavijitphong, Patoomratana Tuchinda, Saksit Nobsathian

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Neurodegenerative disorders are characterized by chronic and progressive loss of neurons in structure and function related to aging, such as Alzheimer's disease, the latter characterized by the degeneration of cholinergic neurons in basal forebrain connected to the cerebral cortex and hippocampus. Amniotic fluid mesenchymal stem cells (AF-MSCs) have been proposed as one of the candidates for stem cell therapy of nervous system disorders. This study demonstrates that incubation of AF-MSCs, obtained from 16 to 20 week pregnant women, with 10 ng/ml bone morphogenetic protein (BMP)-9 for 48 h in conditioned medium resulted in transdifferentiation to cholinergic neuronal-like cells. This phenomenon could also be obtained with N-benzylcinnamide (PT-3). Pre-treatment for 1 h with 10 nM PT-3 augmented BMP-9 transdifferentiation effect, elevated βIII-tubulin cell numbers and fluorescence intensity of immunoreactive ChAT, ameliorated BMP-9-related production of reactive oxygen species and enhanced anti-apoptosis status of the neuronal-like cells. The transdiffirentiation process was accompanied by increased p53 but decreased Notch1 and SIRT1 (p53 deacetylase) levels, and activation of p38, ERK1/2 MAPK, and PI3K/Akt pathways, in concert with inactivation of JNK, all of which were accentuated by PT-3 pre-treatment. These findings suggest that N-benzylcinnamide may provide a useful adjuvant in BMP-9-induced transdifferentiation of AFMSCs into ultimately cholinergic neurons.

Original languageEnglish (US)
Pages (from-to)6-12
Number of pages7
JournalNeuroscience Letters
Volume610
DOIs
StatePublished - Jan 1 2016
Externally publishedYes

Fingerprint

Growth Differentiation Factor 2
Amniotic Fluid
Mesenchymal Stromal Cells
Cholinergic Neurons
Tubulin
Conditioned Culture Medium
Cell- and Tissue-Based Therapy
Nervous System Diseases
Phosphatidylinositol 3-Kinases
Neurodegenerative Diseases
Cerebral Cortex
Cholinergic Agents
Pregnant Women
Reactive Oxygen Species
Hippocampus
Alzheimer Disease
Stem Cells
Cell Count
Fluorescence
Apoptosis

Keywords

  • Alzheimer's disease
  • Antioxidant
  • Cholinergic neuron
  • Differentiation
  • Mechanism
  • N-Benzylcinnamide

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Potential role of N-benzylcinnamide in inducing neuronal differentiation from human amniotic fluid mesenchymal stem cells. / Thangnipon, Wipawan; Puangmalai, Nicha; Suwanna, Nirut; Soi-ampornkul, Rungtip; Phonchai, Ruchee; Kotchabhakdi, Naiphinich; Mukda, Sujira; Phermthai, Tatsanee; Julavijitphong, Suphakde; Tuchinda, Patoomratana; Nobsathian, Saksit.

In: Neuroscience Letters, Vol. 610, 01.01.2016, p. 6-12.

Research output: Contribution to journalArticle

Thangnipon, W, Puangmalai, N, Suwanna, N, Soi-ampornkul, R, Phonchai, R, Kotchabhakdi, N, Mukda, S, Phermthai, T, Julavijitphong, S, Tuchinda, P & Nobsathian, S 2016, 'Potential role of N-benzylcinnamide in inducing neuronal differentiation from human amniotic fluid mesenchymal stem cells', Neuroscience Letters, vol. 610, pp. 6-12. https://doi.org/10.1016/j.neulet.2015.10.050
Thangnipon, Wipawan ; Puangmalai, Nicha ; Suwanna, Nirut ; Soi-ampornkul, Rungtip ; Phonchai, Ruchee ; Kotchabhakdi, Naiphinich ; Mukda, Sujira ; Phermthai, Tatsanee ; Julavijitphong, Suphakde ; Tuchinda, Patoomratana ; Nobsathian, Saksit. / Potential role of N-benzylcinnamide in inducing neuronal differentiation from human amniotic fluid mesenchymal stem cells. In: Neuroscience Letters. 2016 ; Vol. 610. pp. 6-12.
@article{7c7f10350065470e91ee2a85a79d0792,
title = "Potential role of N-benzylcinnamide in inducing neuronal differentiation from human amniotic fluid mesenchymal stem cells",
abstract = "Neurodegenerative disorders are characterized by chronic and progressive loss of neurons in structure and function related to aging, such as Alzheimer's disease, the latter characterized by the degeneration of cholinergic neurons in basal forebrain connected to the cerebral cortex and hippocampus. Amniotic fluid mesenchymal stem cells (AF-MSCs) have been proposed as one of the candidates for stem cell therapy of nervous system disorders. This study demonstrates that incubation of AF-MSCs, obtained from 16 to 20 week pregnant women, with 10 ng/ml bone morphogenetic protein (BMP)-9 for 48 h in conditioned medium resulted in transdifferentiation to cholinergic neuronal-like cells. This phenomenon could also be obtained with N-benzylcinnamide (PT-3). Pre-treatment for 1 h with 10 nM PT-3 augmented BMP-9 transdifferentiation effect, elevated βIII-tubulin cell numbers and fluorescence intensity of immunoreactive ChAT, ameliorated BMP-9-related production of reactive oxygen species and enhanced anti-apoptosis status of the neuronal-like cells. The transdiffirentiation process was accompanied by increased p53 but decreased Notch1 and SIRT1 (p53 deacetylase) levels, and activation of p38, ERK1/2 MAPK, and PI3K/Akt pathways, in concert with inactivation of JNK, all of which were accentuated by PT-3 pre-treatment. These findings suggest that N-benzylcinnamide may provide a useful adjuvant in BMP-9-induced transdifferentiation of AFMSCs into ultimately cholinergic neurons.",
keywords = "Alzheimer's disease, Antioxidant, Cholinergic neuron, Differentiation, Mechanism, N-Benzylcinnamide",
author = "Wipawan Thangnipon and Nicha Puangmalai and Nirut Suwanna and Rungtip Soi-ampornkul and Ruchee Phonchai and Naiphinich Kotchabhakdi and Sujira Mukda and Tatsanee Phermthai and Suphakde Julavijitphong and Patoomratana Tuchinda and Saksit Nobsathian",
year = "2016",
month = "1",
day = "1",
doi = "10.1016/j.neulet.2015.10.050",
language = "English (US)",
volume = "610",
pages = "6--12",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Potential role of N-benzylcinnamide in inducing neuronal differentiation from human amniotic fluid mesenchymal stem cells

AU - Thangnipon, Wipawan

AU - Puangmalai, Nicha

AU - Suwanna, Nirut

AU - Soi-ampornkul, Rungtip

AU - Phonchai, Ruchee

AU - Kotchabhakdi, Naiphinich

AU - Mukda, Sujira

AU - Phermthai, Tatsanee

AU - Julavijitphong, Suphakde

AU - Tuchinda, Patoomratana

AU - Nobsathian, Saksit

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Neurodegenerative disorders are characterized by chronic and progressive loss of neurons in structure and function related to aging, such as Alzheimer's disease, the latter characterized by the degeneration of cholinergic neurons in basal forebrain connected to the cerebral cortex and hippocampus. Amniotic fluid mesenchymal stem cells (AF-MSCs) have been proposed as one of the candidates for stem cell therapy of nervous system disorders. This study demonstrates that incubation of AF-MSCs, obtained from 16 to 20 week pregnant women, with 10 ng/ml bone morphogenetic protein (BMP)-9 for 48 h in conditioned medium resulted in transdifferentiation to cholinergic neuronal-like cells. This phenomenon could also be obtained with N-benzylcinnamide (PT-3). Pre-treatment for 1 h with 10 nM PT-3 augmented BMP-9 transdifferentiation effect, elevated βIII-tubulin cell numbers and fluorescence intensity of immunoreactive ChAT, ameliorated BMP-9-related production of reactive oxygen species and enhanced anti-apoptosis status of the neuronal-like cells. The transdiffirentiation process was accompanied by increased p53 but decreased Notch1 and SIRT1 (p53 deacetylase) levels, and activation of p38, ERK1/2 MAPK, and PI3K/Akt pathways, in concert with inactivation of JNK, all of which were accentuated by PT-3 pre-treatment. These findings suggest that N-benzylcinnamide may provide a useful adjuvant in BMP-9-induced transdifferentiation of AFMSCs into ultimately cholinergic neurons.

AB - Neurodegenerative disorders are characterized by chronic and progressive loss of neurons in structure and function related to aging, such as Alzheimer's disease, the latter characterized by the degeneration of cholinergic neurons in basal forebrain connected to the cerebral cortex and hippocampus. Amniotic fluid mesenchymal stem cells (AF-MSCs) have been proposed as one of the candidates for stem cell therapy of nervous system disorders. This study demonstrates that incubation of AF-MSCs, obtained from 16 to 20 week pregnant women, with 10 ng/ml bone morphogenetic protein (BMP)-9 for 48 h in conditioned medium resulted in transdifferentiation to cholinergic neuronal-like cells. This phenomenon could also be obtained with N-benzylcinnamide (PT-3). Pre-treatment for 1 h with 10 nM PT-3 augmented BMP-9 transdifferentiation effect, elevated βIII-tubulin cell numbers and fluorescence intensity of immunoreactive ChAT, ameliorated BMP-9-related production of reactive oxygen species and enhanced anti-apoptosis status of the neuronal-like cells. The transdiffirentiation process was accompanied by increased p53 but decreased Notch1 and SIRT1 (p53 deacetylase) levels, and activation of p38, ERK1/2 MAPK, and PI3K/Akt pathways, in concert with inactivation of JNK, all of which were accentuated by PT-3 pre-treatment. These findings suggest that N-benzylcinnamide may provide a useful adjuvant in BMP-9-induced transdifferentiation of AFMSCs into ultimately cholinergic neurons.

KW - Alzheimer's disease

KW - Antioxidant

KW - Cholinergic neuron

KW - Differentiation

KW - Mechanism

KW - N-Benzylcinnamide

UR - http://www.scopus.com/inward/record.url?scp=84949870425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949870425&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2015.10.050

DO - 10.1016/j.neulet.2015.10.050

M3 - Article

VL - 610

SP - 6

EP - 12

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

ER -